Health Care & Life Sciences » Pharmaceuticals | Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,978
2,609
3,505
2,515
1,994
2,383
Depreciation, Depletion & Amortization
247
264
306
321
341
339
Other Funds
7
67
-
-
107
711
Funds from Operations
1,883
2,585
2,292
2,207
1,636
2,011
Changes in Working Capital
123
244
179
311
674
270
Net Operating Cash Flow
2,006
2,342
2,113
2,519
2,311
2,282
Capital Expenditures
1,474
621
734
426
562
Sale of Fixed Assets & Businesses
2
15
801
116
166
Purchase/Sale of Investments
767
1,165
528
153
1,453
Net Investing Cash Flow
729
2,094
635
218
2,513
Cash Dividends Paid - Total
659
307
345
709
1,212
Issuance/Reduction of Debt, Net
660
231
6
-
4
Net Financing Cash Flow
1,313
552
339
2,155
1,614
Net Change in Cash
36
304
1,139
146
1,816
Free Cash Flow
938
1,962
1,608
2,237
1,842
Net Assets from Acquisitions
25
-
124
62
664
Other Sources
2
4
-
-
-
Change in Capital Stock
-
53
-
1,445
290
Other Uses
-
326
50
-
-

About Sihuan Pharmaceutical Holdings Group

View Profile
Address
21/F, Building 2
Beijing Beijing 100025
China
Employees -
Website http://www.sihuanpharm.com
Updated 07/08/2019
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It focuses on the field of cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.